| NCT07383506 |
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors |
| NCT07407959 |
Screening and Staging of Benign vs Malignant Pelvic Abnormalities |
| NCT04916990 |
Improving Care for Rural Patients With Solid Tumors |
| NCT05559879 |
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma |
| NCT06276491 |
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
| NCT04977453 |
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors |
| NCT06315257 |
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients |
| NCT06586957 |
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors |
| NCT07306559 |
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) |
| NCT04016389 |
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery |
| NCT07909031 |
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT07890402 |
A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community |
| NCT07631572 |
Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer |
| NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
| NCT06465069 |
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors |
| NCT07109726 |
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations |
| NCT07524322 |
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors |
| NCT05941507 |
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors |
| NCT05721976 |
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study |
| NCT07594015 |
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance |
| NCT07182149 |
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors |
| NCT06999187 |
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas |
| NCT06850402 |
Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care |
| NCT06814496 |
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors |
| NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
| NCT07345897 |
Emergency Department-based Cervical Cancer Screening Through Self-sampling |
| NCT06203106 |
NYSCF Scientific Discovery Biobank |
| NCT07444814 |
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors |
| NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
| NCT03422198 |
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer |
| NCT03564340 |
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
| NCT06365905 |
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding |
| NCT05761561 |
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer |
| NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. |
| NCT07470853 |
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. |
| NCT05975593 |
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial |
| NCT06535607 |
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors |
| NCT06330064 |
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) |
| NCT07281599 |
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer |
| NCT06529809 |
Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer |
| NCT07262619 |
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors |
| NCT05990426 |
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy |
| NCT03968406 |
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers |
| NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
| NCT07278986 |
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer |
| NCT07382583 |
Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer |
| NCT04512144 |
Mindfulness in Endometrial and Cervical Cancer |
| NCT04865887 |
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer |
| NCT05475171 |
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) |
| NCT05103683 |
First in Human Study of TORL-1-23 in Participants With Advanced Cancer |
| NCT04774419 |
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery |
| NCT04570553 |
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers |
| NCT05283330 |
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors |
| NCT07281430 |
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) |
| NCT07106359 |
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome |
| NCT06047379 |
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis |
| NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
| NCT06481592 |
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. |
| NCT05377996 |
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors |
| NCT05512208 |
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib |
| NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
| NCT07327489 |
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) |
| NCT05856981 |
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors |
| NCT07336134 |
PopSci CHW4CervixHealth |
| NCT04073706 |
Sentinel Node Biopsy in Endometrial Cancer |
| NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
| NCT06340568 |
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer |
| NCT06686043 |
HPV Vaccine, Imiquimod, and Metformin Combination Trial |
| NCT06855706 |
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study |
| NCT04300556 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types |
| NCT07867002 |
Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer |
| NCT06825689 |
Unidos Contra el VPH |
| NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
| NCT07020221 |
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors |
| NCT07351110 |
Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions. |
| NCT03675893 |
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer |
| NCT06331468 |
Hypofractionated Radiochemotherapy |
| NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
| NCT06527157 |
Investigations of Reproductive Cancers in Women |
| NCT06840886 |
A Study of PHST001 in Advanced Solid Tumors |
| NCT07318051 |
Sample Collection for Ongoing Research and Product Evaluation Study |
| NCT04389632 |
A Study of Sigvotatug Vedotin in Advanced Solid Tumors |
| NCT06952504 |
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) |
| NCT07664735 |
A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer. |
| NCT07216703 |
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) |
| NCT06266338 |
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) |
| NCT07643012 |
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer |
| NCT07198074 |
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer |
| NCT06128551 |
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors |
| NCT07814248 |
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors |
| NCT06952660 |
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer |
| NCT05902988 |
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer |
| NCT06666192 |
The Ohio State University (OSU) SCREEN Community Program |
| NCT07011836 |
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women |
| NCT07622901 |
Fasting InTervention for Endometrial Cancer |
| NCT05372484 |
Rice Technologies for Cervical Cancer Screening and Diagnosis |
| NCT07022483 |
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting |
| NCT07318415 |
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer |
| NCT00005095 |
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention |
| NCT05639972 |
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers |
| NCT06369155 |
Azenosertib in Uterine Serous Carcinoma: Biomarker Study |
| NCT05049538 |
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers |
| NCT05952141 |
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana |
| NCT07166094 |
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer |
| NCT07419841 |
A Phase 1 Study of the Safety and Tolerability of CTX-10726 |
| NCT06416150 |
Reducing Urban Cervical Cancer Disparities |
| NCT07662824 |
Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy |
| NCT07542704 |
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies |
| NCT05646316 |
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer |
| NCT02993900 |
Image-Guided Gynecologic Brachytherapy |
| NCT07318324 |
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer |
| NCT07292818 |
Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies |
| NCT05592626 |
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors |
| NCT06677190 |
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin |
| NCT04567771 |
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer |
| NCT04895709 |
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors |
| NCT07186842 |
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 |
| NCT06677112 |
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer |
| NCT06974110 |
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors |
| NCT07229313 |
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT06253494 |
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer |
| NCT05548296 |
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma |
| NCT07216105 |
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors |
| NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
| NCT07741968 |
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer |
| NCT04329494 |
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer |
| NCT07453459 |
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening |
| NCT05579366 |
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
| NCT06239194 |
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors |
| NCT05797831 |
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer |
| NCT05768139 |
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
| NCT06964009 |
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer |
| NCT07189871 |
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors |
| NCT05867251 |
Study of AVZO-021 in Patients With Advanced Solid Tumors |
| NCT05838521 |
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer |
| NCT07807345 |
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic |
| NCT04291612 |
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease |
| NCT04486352 |
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer |
| NCT07213609 |
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors |
| NCT04585750 |
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) |
| NCT07749586 |
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors |
| NCT06242470 |
A Study of MGC026 in Participants With Advanced Solid Tumors |
| NCT06400472 |
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors |
| NCT00900575 |
Cervical Cancer Detection Using Optical Spectroscopy |
| NCT06925724 |
A Study of Ivonescimab in People With Endometrial and Cervical Cancers |
| NCT07503808 |
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types |
| NCT06689956 |
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study |
| NCT05603910 |
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma |
| NCT06906341 |
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers |
| NCT05503797 |
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations |
| NCT06730347 |
A Study of Lorigerlimab in Participants With Advanced Solid Tumors |
| NCT07285044 |
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas |
| NCT06293898 |
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors |
| NCT07286331 |
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01) |
| NCT06270706 |
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors |
| NCT07121543 |
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy |
| NCT05142033 |
Avera Cancer Sequencing and Analytics Protocol (ASAP) |
| NCT07407647 |
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer |
| NCT04657068 |
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors |
| NCT04743674 |
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment |
| NCT05051722 |
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer |
| NCT05489211 |
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) |
| NCT02012699 |
Integrated Cancer Repository for Cancer Research |
| NCT07197554 |
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies |
| NCT04683653 |
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer |
| NCT07044336 |
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) |
| NCT07114601 |
A Study of LY4257496 in Participants With Cancer (OMNIRAY) |
| NCT04038619 |
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients |
| NCT07755436 |
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. |
| NCT07415681 |
GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries |
| NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
| NCT05916196 |
[18F]FES PET/.CT in Uterine Cancer |
| NCT04586959 |
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer |
| NCT05919264 |
FOG-001 in Locally Advanced or Metastatic Solid Tumors |
| NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
| NCT07214584 |
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy |
| NCT07059884 |
Distance-Based Exercise to Preserve Function and Prevent Disability |
| NCT04093388 |
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama |
| NCT03832361 |
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer |
| NCT06760819 |
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) |
| NCT04165772 |
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors |
| NCT06042543 |
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs |
| NCT07227168 |
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer |
| NCT07447895 |
Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies |
| NCT04851119 |
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors |
| NCT05979610 |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies |
| NCT07223424 |
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy |
| NCT07022470 |
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT). |
| NCT07270666 |
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer |
| NCT05758688 |
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer |
| NCT07406087 |
Navigation Intervention for Adolescent and Young Adult Cancer Survivors |
| NCT05903131 |
Uterine Preservation Via Lifestyle Transformation |
| NCT06096688 |
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction |
| NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
| NCT04723095 |
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix |
| NCT06463028 |
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer |
| NCT06040970 |
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer |
| NCT06492070 |
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers |
| NCT06349642 |
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform |
| NCT06515613 |
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors |
| NCT05997017 |
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer |
| NCT07064018 |
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies |
| NCT06444815 |
A Study of VET3-TGI in Patients With Solid Tumors |
| NCT04104776 |
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas |
| NCT05606133 |
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers |
| NCT06395519 |
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies |
| NCT04857528 |
Detecting HPV DNA in Anal and Cervical Cancers |
| NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies |
| NCT06695845 |
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors |
| NCT07107334 |
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia |
| NCT06751329 |
A Study of DM002 in Patients With Advanced Solid Tumors |
| NCT06157151 |
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer |
| NCT07091032 |
Building Connections |
| NCT07436793 |
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial |
| NCT05542407 |
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer |
| NCT05950464 |
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer |
| NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
| NCT06319963 |
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer |
| NCT06708429 |
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System |
| NCT05669430 |
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies |
| NCT04831580 |
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer |
| NCT06409052 |
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women |
| NCT05977621 |
Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking |
| NCT06989112 |
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer |
| NCT06993844 |
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors |
| NCT03538665 |
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons |
| NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
| NCT04590326 |
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab |
| NCT06172478 |
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors |
| NCT05686226 |
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers |
| NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
| NCT07927244 |
Improving Rural Endometrial Cancer Care |
| NCT07458347 |
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation |
| NCT07075731 |
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy |
| NCT04196257 |
BP1001-A in Patients With Advanced or Recurrent Solid Tumors |
| NCT05208762 |
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors |
| NCT07084168 |
Multimedia Aid for Genetic Testing in Gynecologic Oncology |
| NCT07770100 |
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) |
| NCT06943521 |
A Study of MT-4561 in Patients With Various Advanced Solid Tumors |
| NCT07044505 |
Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery |
| NCT07139977 |
Study of EV for Recurrent Endometrial Carcinoma |
| NCT05564377 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial |
| NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
| NCT07467772 |
Ph 2 Elacestrant in ER Positive Uterine Sarcomas |
| NCT05691010 |
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer |
| NCT07227077 |
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial |
| NCT07220239 |
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome |
| NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer |
| NCT06128304 |
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services |
| NCT07578649 |
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer |
| NCT07527143 |
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer |
| NCT05983432 |
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors |
| NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
| NCT07220512 |
The Better, Harder, Faster, Stronger Study |
| NCT06872346 |
Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT |
| NCT05092373 |
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax |
| NCT06910657 |
IDOV-Immune for Advanced Solid Tumors |
| NCT06538337 |
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers |
| NCT06366347 |
ALPINE: Maintenance Letrozole/Abemaciclib |
| NCT06795009 |
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer |
| NCT07224464 |
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. |
| NCT07062016 |
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer |
| NCT07209449 |
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer |
| NCT05914116 |
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
| NCT07124000 |
DESTINY-PANTUMOUR04 |
| NCT05640999 |
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER |
| NCT07065552 |
Tirzepatide in Obesity-Driven Endometrial Cancer |
| NCT04107181 |
Pilot Study for Speculum Free Cervical Cancer Screening |
| NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
